NVLX "We are honored that TD2 and Dr. Von Hoff will play a pivotal role in the development of our treatment for patients with advanced pancreatic cancer that combines the proprietary Cell-in-a-Box® live-cell encapsulation technology with the cancer drug ifosfamide.
http://www.stockwatch.com/News/Item.aspx?bid=...p;region=U